The FDA has received over 40 cases of moderate to severe burns from topical pain relievers containing menthol, methyl salicylate, capsaicin, and/or combination of these. Most cases involved products containing greater than 3% menthol or 10% methyl salicylate.  Serious burns have occurred after only one application and at this time there is no way to predict the reaction.  Check out this FDA update for a list of product do’s and don’ts.  How many of these tips do you use when counseling patients about these products?

For more information, please visit the FDA

 

Advertisements